Company Summary - Omega Diagnostics Group PLC (LSE:ODX)
10.62p
0.00p
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £9.050m
NEW Explore our new and improved report for Omega Diagnostics Group PLC >>
Gain access to various premium features such as detailed information on financial reports, broker forecasts, directors and shareholders information.
Summary
Manufacture, development and distribution of medical diagnostic products
| Financials - Interim (25/11/2011) | ||
|---|---|---|
| Turnover | £m | 5.53 |
| Pre-tax Profit | £m | 0.17 |
| EPS | p | 0.10 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| David Evans | Chairman |
| Andrew Shepherd | Chief Executive |
| Kieron Harbinson | Finance Director & Company Sec |
Products Brands & Subsidiaries
Products & Brands
Genarrayt; Immutrep; Micropath
Subsidiaries
Cambridge Nutritional Sciences Ltd; Genesis Diagnostics Ltd; Omega Diagnostics Ltd; Co-Tek (South West) Ltd; Bealaw (693) Ltd...
Broker Sentiment (2 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Director/PDMR Shareholding | 30/01/2012 |
| Directorate Change | 17/01/2012 |
| Interim Results | 25/11/2011 |